Genetic mapping of Alzheimer’s brain changes in diverse US and Brazilian groups

Whole Genome Sequencing and Admixture Analyses of Neuropathologic Traits in Diverse Cohorts in USA and Brazil

NIH-funded research Rush University Medical Center · NIH-11399651

This project uses whole genome sequencing of autopsied brains—especially from people of African ancestry and mixed-ancestry Brazilians—to find genetic changes linked to Alzheimer’s and related brain damage.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionRush University Medical Center NIH-funded
Lab location1 site (Chicago, United States)
Project IDNIH-11399651 on NIH RePORTER

What this research studies

Researchers will sequence the full genomes from thousands of donated brains and combine those data with detailed neuropathology and clinical information. They will focus on admixed populations, including people of African ancestry and Brazilians with mixed European, African, and Native ancestry, to find ancestry-related genetic signals. The team will use admixture mapping and compare findings across cohorts in Sao Paulo and multiple US sites to find genes and proteins tied to Alzheimer’s pathologic traits. Results aim to reveal disease drivers that were missed when studies included mostly non-Latino white participants.

Who could benefit from this research

Good fit: Ideal participants are people with Alzheimer’s or related dementias (or their families) who are willing to participate in research and consider brain donation, especially those of African or admixed Brazilian ancestry.

Not a fit: People without ties to the involved cohorts or who cannot provide consent for tissue donation or clinical data are unlikely to participate or benefit directly from this grant.

Why it matters

Potential benefit: If successful, this work could uncover genetic targets that improve diagnosis, risk prediction, or lead to new treatments that better serve diverse populations.

How similar studies have performed: Previous multi-omics and sequencing work found molecular drivers in largely non-Latino white groups, but applying these methods in African ancestry and admixed Brazilian populations is newer and less explored.

Where this research is happening

Chicago, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Alzheimer disease dementiaAlzheimer syndromeAlzheimer's Disease
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.